Citigroup
C
American Express
AXP
Bank of America
BAC
Moody's
MCO
DaVita
DVA
US Stock MarketDetailed Quotes
AXSM Axsome Therapeutics
- 128.940
- +1.850+1.46%
Trading Feb 26 09:59 ET
6.29BMarket Cap-21.53P/E (TTM)
130.000High126.430Low65.19KVolume128.399Open127.090Pre Close8.35MTurnover0.18%Turnover RatioLossP/E (Static)48.77MShares139.13052wk High110.30P/B4.73BFloat Cap64.11052wk Low--Dividend TTM36.67MShs Float139.130Historical High--Div YieldTTM2.81%Amplitude1.940Historical Low128.150Avg Price1Lot Size
Axsome Therapeutics Key Stats
EPS
According to the latest financial report of Axsome Therapeutics, the latest earnings per share (TTM) for the company is -1.54. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Axsome Therapeutics's free cash flow? The latest report shows it as -26.23M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Axsome Therapeutics shows that the company's current ratio is 2.11, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Axsome Therapeutics, the quick ratio is 1.99, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Axsome Therapeutics? The latest ROE figure is -99.94%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Axsome Therapeutics, the total asset return on investment (ROA) is -13.26%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Axsome Therapeutics's latest financial report to see how their gross margin is doing - currently at 91.15%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Axsome Therapeutics, the net profit margin is -63.08%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.